Daily non-political popular news in brief.

Gene therapy protocol at UCSD activates immune system in patients with leukemia

02-11-2008 · EurekAlert!

A research team at the Moores Cancer Center at University of California, San Diego reports that patients with chronic lymphocytic leukemia who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells. The study will be published on line the week of Feb. 11-15 in the online edition of the Proceedings of the National Academy of Science.

Keywords: gene, therapy, protocol, ucsd, activates, immune, system, patients, leukemia, activate, patient

« Previous | Next »

Similar news on "Gene therapy protocol at UCSD activates immune system in patients with leukemia":

Phase I study of novel gene therapy for HIV
11-06-2006 · EurekAlert!
The results are in for Phase I clinical trials of a gene therapy for AIDS. The trial was conducted at U-Penn where five patients with chronic HIV who had failed prior therapies were given a one-time infusion. They all tolerated the therapy and showed improved immune system response. This is the first publication of an effective gene therapy for AIDS to show positive clinical results in the peer review literature.
Similar news · Read more »
Firefly genes allow testing of new therapy against lymphoma
12-19-2007 · EurekAlert!
Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
Similar news · Read more »
Gene's activity points to more lethal subtype of AML
07-09-2007 · EurekAlert!
A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy. The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.
Similar news · Read more »
University of Pittsburgh discovers genetic 'shut down' trigger in healthy immune cells
05-09-2007 · EurekAlert!
A fundamental genetic mechanism that shuts down an important gene in healthy immune system cells has been discovered that could one day lead to new therapies against infections, leukemia and other cancers. Results of a University of Pittsburgh School of Medicine study on the mechanism, called a somatic stop-codon mutation, are being reported today in the online journal PLoS ONE, published by the Public Library of Science.
Similar news · Read more »
Pancreatic cancer vaccine halts progression of disease in some patients
04-17-2007 · EurekAlert!
A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
Similar news · Read more »
Debate over safety of gene therapy trials focuses on issue of informed consent
01-22-2008 · EurekAlert!
Can a patient who agrees to participate in a safety study of a gene therapy protocol give truly informed consent and understand the risks involved when the consent forms are highly technical and the physician or institution seeking their consent has a stake in the study and its outcome?
Similar news · Read more »
Vaccine improves event-free survival for leukemia patients
12-09-2007 · EurekAlert!
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than nonresponders, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Similar news · Read more »
Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
MGH study examines impact of infection with both HIV and hepatitis C virus
12-11-2006 · EurekAlert!
In a report in the December issue of PLOS Medicine, a group of researchers from the Partners AIDS Research Center at Massachusetts General Hospital report one of the first studies of how HIV infection impacts immune system functions involved with hepatitis C virus control. Their findings suggest that beginning antiretroviral therapy earlier than is generally recommended may help preserve HCV control in patients infected with both viruses.
Similar news · Read more »
Aggressive therapy best for certain AML patients
08-01-2007 · EurekAlert!
A new study suggests that acute leukemia patients whose cancer cells show a genetic change that usually predicts a swift return of the disease following remission may remain disease-free longer when given aggressive therapy. The findings apply to people with acute myeloid leukemia whose cancer cells have normal-looking chromosomes and a gene mutation called MLL-PTD.
Similar news · Read more »